Search tips
Search criteria 


Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. 1992 January; 36(1): 32–38.
PMCID: PMC189221

Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits.


Although composite data from separate subjects can be used to generate single-subject estimates, intersubject variation precludes rigorous ocular pharmacokinetic analysis. Therefore, a rabbit model in which sequential aqueous and vitreous humor samples were obtained following the administration of the quinolone fleroxacin was developed. Mean data from individual animals were used for pharmacokinetic analysis. Following direct intravitreal or systemic drug administration, sequential paracenteses did not alter pharmacokinetic constants or ocular penetration and were not associated with an increase in ocular protein; contamination of vitreous humor with blood was minimal (less than 0.1%). Following direct injection or intravenous administration, vitreous humor concentration-time data were best described by one- and two-compartment models, respectively. The maximum concentration and the penetration into the aqueous and vitreous humors were 1.54 and 0.5 micrograms/ml and 27 and 10%, respectively. Elimination rates from aqueous and vitreous humors and serum were similar following parenteral drug administration. Drug elimination following direct injection was rapid, and the elimination rate from the vitreous humor was not prolonged by the coadministration of probenecid. Our animal model provides a new approach to the rigorous examination of the ocular pharmacokinetics of quinolone antimicrobial agents in the eye.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Axelrod JL, Kochman RS. Cefamandole levels in primary aqueous humor in man. Am J Ophthalmol. 1978 Mar;85(3):342–348. [PubMed]
  • Barza M, Kane A, Baum J. The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor. Invest Ophthalmol Vis Sci. 1982 Jun;22(6):720–726. [PubMed]
  • Barza M, Kane A, Baum J. Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys. Invest Ophthalmol Vis Sci. 1983 Dec;24(12):1602–1606. [PubMed]
  • Chow RT, Dougherty TJ, Fraimow HS, Bellin EY, Miller MH. Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12. Antimicrob Agents Chemother. 1988 Aug;32(8):1113–1118. [PMC free article] [PubMed]
  • Cobo LM, Forster RK. The clearance of intravitreal gentamicin. Am J Ophthalmol. 1981 Jul;92(1):59–62. [PubMed]
  • Conway BP, Campochiaro PA. Macular infarction after endophthalmitis treated with vitrectomy and intravitreal gentamicin. Arch Ophthalmol. 1986 Mar;104(3):367–371. [PubMed]
  • Diamond JG. Intraocular management of endophthalmitis. A systematic approach. Arch Ophthalmol. 1981 Jan;99(1):96–99. [PubMed]
  • Driebe WT, Jr, Mandelbaum S, Forster RK, Schwartz LK, Culbertson WW. Pseudophakic endophthalmitis. Diagnosis and management. Ophthalmology. 1986 Apr;93(4):442–448. [PubMed]
  • Fern AI, Sweeney G, Doig M, Lindsay G. Penetration of ciprofloxacin into aqueous humor. Trans Ophthalmol Soc U K. 1986;105(Pt 6):650–652. [PubMed]
  • Griggs DJ, Wise R, Kirkpatrick B, Ashby JP. The metabolism and pharmacokinetics of fleroxacin in healthy subjects. J Antimicrob Chemother. 1988 Oct;22 (Suppl 500):191–194. [PubMed]
  • Kojima T, Inoue M, Mitsuhashi S. In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrob Agents Chemother. 1989 Nov;33(11):1980–1988. [PMC free article] [PubMed]
  • Kusajima H, Ooie T, Kawahara F, Uchida H. High-performance liquid chromatographic determination of 6,8-difluoro-1-(2-fluoroethyl)-1,4- dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid and its metabolites in laboratory animals. J Chromatogr. 1986 Aug 22;381(1):137–148. [PubMed]
  • Lesar TS, Fiscella RG. Antimicrobial drug delivery to the eye. Drug Intell Clin Pharm. 1985 Sep;19(9):642–654. [PubMed]
  • Massin-Cochereau I, Le Hoang P, Weiser M, Rousselie F. Pefloxacine et infections oculaires graves. Bull Soc Ophtalmol Fr. 1987 Jun-Jul;87(6-7):735–738. [PubMed]
  • Mayers M, Rush D, Madu A, Motyl M, Miller MH. Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits. Antimicrob Agents Chemother. 1991 Sep;35(9):1791–1798. [PMC free article] [PubMed]
  • Olson JC, Flynn HW, Jr, Forster RK, Culbertson WW. Results in the treatment of postoperative endophthalmitis. Ophthalmology. 1983 Jun;90(6):692–699. [PubMed]
  • Oum BS, D'Amico DJ, Wong KW. Intravitreal antibiotic therapy with vancomycin and aminoglycoside. An experimental study of combination and repetitive injections. Arch Ophthalmol. 1989 Jul;107(7):1055–1060. [PubMed]
  • Pflugfelder SC, Hernández E, Fliesler SJ, Alvarez J, Pflugfelder ME, Forster RK. Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin. Arch Ophthalmol. 1987 Jun;105(6):831–837. [PubMed]
  • Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endophthalmitis. Review of 36 cases. Ophthalmology. 1982 Aug;89(8):921–929. [PubMed]
  • Salvanet-Bouccara A, Feys J, Koffi-Gue B, Fisch A, Cherifi M, Forestier F. Endophtalmies bactériennes: traitement par l'association fosfomycine pefloxacine. A propos de 9 cas. Bull Soc Ophtalmol Fr. 1989 Nov;89(11):1281–1286. [PubMed]
  • Sedlock DM, Dobson RA, Deuel DM, Lesher GY, Rake JB. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria. Antimicrob Agents Chemother. 1990 Apr;34(4):568–575. [PMC free article] [PubMed]
  • Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm. 1977 Oct;5(5):445–479. [PubMed]
  • Shiba K, Saito A, Shimada J, Hori S, Kaji M, Miyahara T, Kusajima H, Kaneko S, Saito S, Ooie T, et al. Renal handling of fleroxacin in rabbits, dogs, and humans. Antimicrob Agents Chemother. 1990 Jan;34(1):58–64. [PMC free article] [PubMed]
  • Smith RP, Baltch AL, Hammer MC, Conroy JV. In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains. Antimicrob Agents Chemother. 1988 Sep;32(9):1450–1455. [PMC free article] [PubMed]
  • Walsh A, Haft DA, Miller MH, Loran MR, Friedman AH. Ocular penetration of 5-fluorocytosine. Invest Ophthalmol Vis Sci. 1978 Jul;17(7):691–694. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)